Dose-Escalating Study of Propiverine Hydrochloride in Children Suffering From Overactive Bladder
Status:
Completed
Trial end date:
2005-12-01
Target enrollment:
Participant gender:
Summary
The open-label dose-escalating two-centre study was designed to assess the pharmacokinetics
as well as safety, tolerability and efficacy parameters of propiverine in patients 5-10 years
of age suffering from frequency-urgency-syndrome and urinary incontinence indicative of
detrusor overactivity (overactive bladder) for determination of the recommended dose in
children.